- Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report
-
Kumar R, Hsiang JC, Tan J, Thurairajah PH
- KMID: 2459794
- Clin Mol Hepatol.
- 2019 Sep;25(3):326-330.
- doi: 10.3350/cmh.2018.0063
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
-
Patoulias , Imprialos , Stavropoulos K, Doumas M
- KMID: 2459795
- Clin Mol Hepatol.
- 2019 Sep;25(3):331-332.
- doi: 10.3350/cmh.2019.0034
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
-
Yu JH, Lee JW
- KMID: 2459789
- Clin Mol Hepatol.
- 2019 Sep;25(3):280-282.
- doi: 10.3350/cmh.2018.0104
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Sarcopenia: Ammonia metabolism and hepatic encephalopathy
-
Jindal A, Jagdish RK
- KMID: 2459788
- Clin Mol Hepatol.
- 2019 Sep;25(3):270-279.
- doi: 10.3350/cmh.2019.0015
Sarcopenia (loss of muscle mass and/or strength) frequently complicates liver cirrhosis and adversely affects the quality of life; cirrhosis related liver decompensation and significantly decreases wait-list and post-liver transplantation survival.... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
-
Na SK, Song BC
- KMID: 2459785
- Clin Mol Hepatol.
- 2019 Sep;25(3):234-244.
- doi: 10.3350/cmh.2018.0108
Hepatitis C virus (HCV) infection is a major risk factor for liver cirrhosis and hepatocellular carcinoma (HCC), and is a leading cause of liver-related deaths worldwide. Recently available direct-acting antiviral... -
- CITED
-
- Close
- SHARE
-
- Close
- Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
-
Kim YY, Park MS, Aljoqiman , Choi JY, Kim MJ
- KMID: 2459784
- Clin Mol Hepatol.
- 2019 Sep;25(3):223-233.
- doi: 10.3350/cmh.2018.0107
Gadoxetic acid, a hepatocyte-specific magnetic resonance imaging (MRI) contrast agent, has emerged as an important tool for hepatocellular carcinoma (HCC) diagnosis. Gadoxetic acid-enhanced MRI is useful for the evaluation of... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
-
Hanouneh I, Alkhouri N, Singal AG
- KMID: 2459787
- Clin Mol Hepatol.
- 2019 Sep;25(3):264-269.
- doi: 10.3350/cmh.2019.1001
Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death worldwide. Prognosis and treatment options largely depend on tumor stage at diagnosis, with curative treatments only available... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes
-
Banitalebi E, Faramarzi , Nasiri S, Mardaniyan M, Rabiee V
- KMID: 2459791
- Clin Mol Hepatol.
- 2019 Sep;25(3):294-304.
- doi: 10.3350/cmh.2018.0086
BACKGROUND/AIMS: Fatty liver is a clinical and pathologic condition in individuals with type 2 diabetes (T2D). The purpose of this study is to examine the effects of different exercise modalities... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
-
Kim TH, Kim SY, Tang A, Lee JM
- KMID: 2459786
- Clin Mol Hepatol.
- 2019 Sep;25(3):245-263.
- doi: 10.3350/cmh.2018.0090
The goal of this review is to present the similarities and differences among the latest guidelines for noninvasive diagnosis of hepatocellular carcinoma (HCC) of American Association for the Study of... -
- CITED
-
- Close
- SHARE
-
- Close
- Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
-
Hassan EA, Rehim AS, Abdel-Malek MO, Ahmed AO, Abbas NM
- KMID: 2459793
- Clin Mol Hepatol.
- 2019 Sep;25(3):317-325.
- doi: 10.3350/cmh.2018.0097
BACKGROUND/AIMS: Cellulitis is a common infection in patients with liver cirrhosis. We aimed to compare risk factors, microbial aspects, and outcomes of cellulitis in compensated and decompensated hepatitis C virus... -
- CITED
-
- Close
- SHARE
-
- Close
- Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
-
Wong L, Bozhilov K, Hernandez , Kwee S, Chan O, Ellis L, LeMarchand L
- KMID: 2459792
- Clin Mol Hepatol.
- 2019 Sep;25(3):305-316.
- doi: 10.3350/cmh.2019.0004
BACKGROUND/AIMS: Inflammation-based scores, such as the neutrophil-to-lymphocyte ratio (NLR), have been associated with prognosis in hepatocellular carcinoma (HCC); but variable cut-off values and potential lack of specificity have limited the... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
-
Kim DS, Jeon MY, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU
- KMID: 2459790
- Clin Mol Hepatol.
- 2019 Sep;25(3):283-293.
- doi: 10.3350/cmh.2018.0054
BACKGROUND/AIMS: The influence of hepatic steatosis (HS) on chronic hepatitis B (CHB) is unclear. We evaluated the influence of the degree of HS, assessed using the controlled attenuation parameter (CAP)... -
- CITED
-
- Close
- SHARE
-
- Close
